Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 3/20 | 0.47 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7111136 | 0.89 | CTRB1 (0.55) | CPA1TRPM8CTSLCTSBCTRB1 | |
| SCHEMBL7663931 | 0.86 | CPA1 (0.55) | CPA1 | |
| SCHEMBL3471057 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL7810113 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL6861203 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL7111203 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL2630734 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL8838391 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL7815696 | 0.84 | KLK5 (0.60) | KLK5CTSLCTSB | |
| SCHEMBL9058446 | 0.83 | KLK5 (0.49) | KLK5TRPM8MMP8CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030040644-A1 | Synthesis of nitroalcohol diastereomers | PHARM-ECO LABORATORIES, INC. | 2003-02-27 | — | — | US | disclosed |
| US-6462221-B1 | 3-SUBSTITUTED-3-AMINO-2-HYDROXYPROPANOIC ACID SALT OR 1-NITRO-3-SUBSTITUTE-3-AMINO-2-HYDROXYPROPANOL DIASTEREOMERS OBTAINED FROM SIMULATED MOVING BED SEPARATION | PHARM-ECO LABORATORIES, INC. | 2002-10-08 | — | — | US | disclosed |
| EP-1159253-A2 | SYNTHESIS OF NITROALCOHOL DIASTEREOMERS | Johnson Matthey Pharmaceutical Materials Inc (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000050378-A9 | SYNTHESIS OF NITROALCOHOL DIASTEREOMERS | — | 2001-08-23 | — | — | WO | disclosed |
| WO-2000050378-A2 | SYNTHESIS OF NITROALCOHOL DIASTEREOMERS | PHARM-ECO LABORATORIES, INC. (US) | 2000-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040644-A1 | Synthesis of nitroalcohol diastereomers | ALDH7A1, ADRA1A, ADH1A | CPA1 932/4885KLK5 4074/4885TRPM8 4819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.